Preretinal hemorrhage as a presenting sign of idiopathic macular telangiectasia type 2

被引:3
|
作者
Osher, James M. [1 ,2 ]
Sisk, Robert A. [1 ,2 ]
Petersen, Michael R. [2 ]
机构
[1] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH USA
[2] Cincinnati Eye Inst, 1945 CEI Dr, Cincinnati, OH 45242 USA
来源
CLINICAL OPHTHALMOLOGY | 2015年 / 9卷
关键词
idiopathic macular telangiectasia; juxtafoveal telangiectasia; preretinal hemorrhage; Valsalva retinopathy;
D O I
10.2147/OPTH.S83335
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
We report three cases of idiopathic macular telangiectasia type 2 with temporally decentered preretinal hemorrhage as the presenting sign. The preretinal blood obscured the telangiectatic vessels such that the diagnosis was only evident by fluorescein angiography of the fellow eyes, which had near-normal vision. The preretinal hemorrhage was associated with Valsalva maneuver in one patient and with type 3 subretinal neovascularization in one patient. We speculate that the vascular dilations in idiopathic macular telangiectasia type 2 may increase patients' susceptibility to rupture and hemorrhage with increased venous pressure.
引用
收藏
页码:1417 / 1420
页数:4
相关论文
共 50 条
  • [21] Efficacy of Macular Hole Surgery in Patients with Idiopathic Macular Telangiectasia Type 2
    Chandra, Rohit
    Pophal, Charles
    Miller, Alexander G.
    Hornik, Joan H.
    Schartman, Jerome P.
    Coney, Joseph M.
    Singerman, Lawrence J.
    Miller, David G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [22] Efficacy of Macular Hole Surgery in Patients with Idiopathic Macular Telangiectasia Type 2
    Miller, Alexander G.
    Chandra, Rohit
    Pophal, Charles
    Schartman, Jerome P.
    Hornik, Joan H.
    Miller, David G.
    OPHTHALMOLOGY RETINA, 2020, 4 (05): : 494 - 497
  • [23] Assessing photoreceptor degeneration in type 2 idiopathic macular telangiectasia
    Sallo, Ferenc B.
    Dubis, Adam M.
    Leung, Irene
    Clemons, Traci E.
    Pauleikhoff, Daniel
    Chew, Emily Y.
    Bird, Alan C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [24] Global Connections to Study Idiopathic Macular Telangiectasia Type 2
    Chew, Emily Y.
    Friedlander, Martin
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 : S3 - S7
  • [25] CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA
    Leung, Irene
    Sallo, Ferenc B.
    Bonelli, Roberto
    Clemons, Traci E.
    Pauleikhoff, Daniel
    Chew, Emily Y.
    Bird, Alan C.
    Peto, Tunde
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 : S43 - S50
  • [26] Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
    Aydogan, Tugba
    Erdogan, Gurkan
    Unlu, Cihan
    Ergin, Ahmet
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2016, 46 (06): : 270 - 273
  • [27] Tamoxifen Use in a Patient with Idiopathic Macular Telangiectasia Type 2
    Behrens, Alice
    Sallam, Ahmed
    Pemberton, John
    Uwaydat, Sami
    CASE REPORTS IN OPHTHALMOLOGY, 2018, 9 (01): : 60 - 66
  • [28] Acute preretinal hemorrhage as presenting clinical sign of eventually life-threatening subarachnoid hemorrhage
    Budde, WM
    Junemann, A
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1998, 213 (02) : 121 - 122
  • [29] Bevacizumab and type 1 idiopathic macular telangiectasia
    C L Koay
    F L M Chew
    S Visvaraja
    Eye, 2011, 25 : 1663 - 1665
  • [30] Bevacizumab and type 1 idiopathic macular telangiectasia
    Koay, C. L.
    Chew, F. L. M.
    Visvaraja, S.
    EYE, 2011, 25 (12) : 1663 - 1665